Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

71989-26-9 - Nepsilon-Boc-Nalpha-Fmoc-L-lysine, 98% - Fmoc-Lys(Boc)-OH - H59182 - Alfa Aesar

H59182 Nepsilon-Boc-Nalpha-Fmoc-L-lysine, 98%

CAS-Nummer
71989-26-9
Synonyme
Fmoc-Lys(Boc)-OH

Größe Preis ($) Menge Verfügbarkeit
5g 35,70
25g 125,00
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

Nepsilon-Boc-Nalpha-Fmoc-L-lysine, 98%

MDL
MFCD00037138
EINECS
276-256-4

Chemische Eigenschaften

Formel
C26H32N2O6
Molmasse
468.54
Schmelzpunkt
130-135°
Löslichkeit
Slightly soluble in water.

Anwendungen

It is used to prepare dimeric RGD peptide-paclitaxel conjugate as model for integrin-targeted drug delivery. It is also used to synthesize DOTA-conjugated multivalent cyclic-RGD peptide dendrimers for tumor targeting and imaging use.

Bemerkungen

Refrigerate. Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from oxidizing agent.

Literaturverweise

Xiaoyuan Chen; Carmen Plasencia; Yingping Hou; and Nouri Neamati. Synthesis and Biological Evaluation of Dimeric RGD Peptide-Paclitaxel Conjugate as a Model for Integrin-Targeted Drug Delivery. J. Med. Chem,2005,48 (4), 1098-1106.

Dijkgraaf, I., et al. Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes. Org. Biomol. Chem,2007, 5(6), 935-944.

Weitere Referenzen

Beilstein
4217767
Harmonized Tariff Code
2924.29
TSCA
No

Empfohlen

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf